Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Classifica tra le azioni #12327
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Prezzo delle azioni
$11.03
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$597.15M
Variazione (1 giorno)
-4.25%
Variazione (1 anno)
-
Paese
US
Scambia Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoria

Il prezzo EIKN con la capitalizzazione del mercato della B
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock
EIKN
$11.03
Capitalizzazione di mercato di Eikon Therapeutics, Inc. Common Stock(EIKN)
Capitalizzazione di mercato: $597.15M
A partire dal August 2026, Eikon Therapeutics, Inc. Common Stock ha una capitalizzazione di mercato pari a $597.15M. Questo rende Eikon Therapeutics, Inc. Common Stock la 12327th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Eikon Therapeutics, Inc. Common Stock dal 2026 al 2026
EIKN in paragone con la classifica dei più popolari stocks
Il prezzo per EIKN Attivo B Capitalizzazione del mercato a B Risultati
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock
$97,229.42 $597.15M
$5.264T +881,399.76%
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock
$86,837.73 $597.15M
$4.701T +787,186.80%
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock
$77,157.06 $597.15M
$4.177T +699,420.08%
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock
$70,511.59 $597.15M
$3.817T +639,171.03%
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock
$52,944.39 $597.15M
$2.866T +479,903.56%